Angiogenic Proteins
- Name
- Angiogenic Proteins
- Accession Number
- DBCAT001798
- Description
Intercellular signaling peptides and proteins that regulate the proliferation of new blood vessels under normal physiological conditions (ANGIOGENESIS, PHYSIOLOGICAL). Aberrant expression of angiogenic proteins during disease states such as tumorigenesis can also result in PATHOLOGICAL ANGIOGENESIS.
- Drugs
Drug Drug Description Endostatin Investigated for use/treatment in cancer/tumors (unspecified), macular degeneration, and diabetic retinopathy. Endostar Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer. - Drugs & Drug Targets
Drug Target Type Endostatin 72 kDa type IV collagenase target Endostatin Matrix metalloproteinase-9 target Endostatin Collagenase 3 target Endostatin Focal adhesion kinase 1 target Endostatin E-selectin target Endostatin Cytochrome P450 19A1 enzyme